OpenVSafe by OpenVAERS
Search V-safe

9KR-19923-78910

2 vaccinations 5 coded responses 23 check-ins 5 free-text entries 0 call cases
Sex
Female
Age at first dose
36-40
ZIP prefix
031 / NH
Registered
2021-03-24
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-03-24
    Registered in v-safe
  2. 2021-03-24
    Dose 1 — Pfizer-BioNTech
  3. 2021-03-24
    Health check-in — day 0, dose 1
    Feeling: Good · None
    Adult check-in
  4. 2021-03-25
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · Muscle or body aches, Abdominal pain
    Adult check-in
  5. 2021-03-26
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Joint pains, Muscle or body aches, Fatigue or tiredness
    Adult check-in
  6. 2021-03-27
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2021-03-28
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2021-03-29
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  9. 2021-03-30
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  10. 2021-03-31
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  11. 2021-04-07
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  12. 2021-04-14
    Dose 2 — Pfizer-BioNTech
  13. 2021-04-14
    Health check-in — day 0, dose 2
    Feeling: Good · Site: Pain · None
    Adult check-in
  14. 2021-04-15
    Survey response — days 1–6 daily, dose 2
    MedDRA: Breast pain — Feeling: Fair · Site: Pain · Fever · Chills, Joint pains, Muscle or body aches, Fatigue or tiredness, Abdominal pain · Be unable to work, Be unable to do your normal daily activities
    Free text: Pain in my breasts
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  15. 2021-04-16
    Survey response — days 1–6 daily, dose 2
    MedDRA: BRCA1 gene mutation, Breast pain, Condition aggravated, Pain in extremity, Pre-existing disease, Vaccine positive rechallenge — Feeling: Good · Site: Pain, Redness · Fatigue or tiredness, Abdominal pain
    Free text: I am BRCA1 positive and I have noticed pain in my under arms and breast tissue. This happened after the first shot too and eventually went away. Please take note. Thanks!
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  16. 2021-04-17
    Survey response — days 1–6 daily, dose 2
    MedDRA: BRCA1 gene mutation, Breast pain — Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tiredness
    Free text: I have pain in my breast tissue that also appeared after the first shot. It is not related to my cycle because I dont have one. BRCA1 positive
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  17. 2021-04-19
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · None
    Adult check-in
  18. 2021-04-21
    Health check-in — day 7, dose 2
    Feeling: Fair · Headache, Muscle or body aches, Fatigue or tiredness
    Adult check-in
  19. 2021-04-28
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  20. 2021-05-05
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  21. 2021-05-12
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  22. 2021-05-20
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  23. 2021-05-26
    Survey response — day 42, dose 2
    MedDRA: Anosmia, Fatigue, Headache, Hypersensitivity, Nasal congestion — Feeling: Good · Be unable to work, Be unable to do your normal daily activities
    Free text: Nasal congestion, headache, fatigue, temporary loss of smell. Suspect this is allergies.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  24. 2021-07-14
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  25. 2021-10-13
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  26. 2022-04-14
    Survey response — 12 months, dose 2
    MedDRA: Cough, Headache, Pre-existing disease, SARS-CoV-2 test negative — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Persistent cough and headache. Presumed to be allergies. Tested neg for COVID
    MedDRA releases: 2024-11 · check-in free text available

Vaccinations

DoseDateManufacturerCo-administered
12021-03-24Pfizer-BioNTech
22021-04-14Pfizer-BioNTech

Free text

Release 7 — days 1–6 daily, dose 2

2021-04-15

Systemic reaction (other): Pain in my breasts

2021-04-16

Systemic reaction (other): I am BRCA1 positive and I have noticed pain in my under arms and breast tissue. This happened after the first shot too and eventually went away. Please take note. Thanks!

2021-04-17

Systemic reaction (other): I have pain in my breast tissue that also appeared after the first shot. It is not related to my cycle because I dont have one. BRCA1 positive

Release 8 — day 42, dose 2

2021-05-26

Symptoms: Nasal congestion, headache, fatigue, temporary loss of smell. Suspect this is allergies.

Release 11 — 12 months, dose 2

2022-04-14

Symptoms: Persistent cough and headache. Presumed to be allergies. Tested neg for COVID

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDAnosmia ✓ ✓ ✓
SDCough · · ✓
SDFatigue ✓ ✓ ✓
SDHeadache ✓ ✓ ✓
SDHypersensitivity ✓ ✓ ✓
SDNasal congestion ✓ ✓ ✓
SDPre-existing disease · · ✓
SDSARS-CoV-2 test negative · · ✓
SROBRCA1 gene mutation ✓ ✓ ✓
SROBreast pain ✓ ✓ ✓
SROCondition aggravated ✓ ✓ ✓
SROPain in extremity ✓ ✓ ✓
SROPre-existing disease ✓ ✓ ✓
SROVaccine positive rechallenge ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release